Bottom line
LHCIX vs JEHSX: the short answer
LHCIX (Lord Abbett Health Care Fund) and JEHSX (Health Sciences Trust) are both mutual funds.
But JEHSX is far broader, holding 173 positions to 61 for LHCIX, so beyond the top names it adds exposure LHCIX doesn't have.
LHCIX is cheaper at 0.78% vs 1.04% — a difference of $26 a year per $10,000 invested.
Over five years, LHCIX returned +4.6% a year vs +4.2% for JEHSX.
Updated Nov 19, 2026
LHCIX vs JEHSX side by side
| LHCIX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Lord Abbett | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.78% | 1.04% |
| Annual cost per $10k | $78 | $104 |
| 10-yr cost on $10k (prospectus) | $3,362 | $1,282 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0.05% |
| 1-yr return | +17.9% | +19.5% |
| 5-yr return (annualized) | +4.6% | +4.2% |
| 10-yr return (annualized) | — | +8.7% |
| Best quarter | — | +23.6% |
| Worst quarter | — | −16.1% |
| Net assets (fund) | $8.6M | $251.3M |
| Number of holdings | 61 | 173 |
| Portfolio turnover | 91% | 68% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of LHCIX's top 25 holdings also appear in JEHSX's top 25.
| Holding | LHCIX | JEHSX |
|---|---|---|
| Eli Lilly & Co | 10.40% | 14.30% |
| UnitedHealth Group Inc | 5.39% | 5.95% |
| Johnson & Johnson | 4.96% | 6.33% |
| Natera Inc | 3.60% | 1.49% |
| Gilead Sciences Inc | 3.53% | 2.95% |
| CVS Health Corp | 3.33% | 0.98% |
| Guardant Health Inc | 2.61% | 1.28% |
| Thermo Fisher Scientific Inc | 2.31% | 2.67% |
| Vertex Pharmaceuticals Inc | 2.24% | 2.38% |
| Protagonist Therapeutics Inc | 1.44% | 0.90% |
Source: SEC Form N-PORT
LHCIX top 10
- Eli Lilly & Co — 10.40%
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Guardant Health Inc — 2.61%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between LHCIX and JEHSX?
Which is cheaper, LHCIX or JEHSX?
Should I own both LHCIX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.